CD1A
Aliases:
This biomarker is also known as:- R4
- CD1a molecule
- differentiation antigen CD1-alpha-3
- HTA1
- cortical thymocyte antigen CD1A
- CD1A antigen, a polypeptide
- epidermal dendritic cell marker CD1a
- cluster of differentiation 1 A
- CD1
- hTa1 thymocyte antigen
- T6
- T-cell surface antigen T6/Leu-6
- CD1a antigen
- CD1A
- FCB6
- T-cell surface glycoprotein CD1a
Description…
CD1A is a transmembrane glycoprotein that is structurally related to the major histocompatibility complex (MHC) proteins and forms heterodimers with beta-2-microglobulin. CD1A functions as an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells.
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Protein |
| HGNC Name: | CD1A |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 2 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- Multianalyte tests for the early detection of cancer: speedbumps and barriers.
- Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
- TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.